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Abstract
Background: For more than 100 years, group A Streptococcus has been identified as a cause of severe and, in many cases,
fatal infections of the female urogenital tract. Due to advances in hospital hygiene and the advent of antibiotics, this type of
infection has been virtually eradicated. However, within the last three decades there has been an increase in severe intra-
and post-partum infections attributed to GAS.
Methodology: We hypothesized that GAS alters its transcriptome to survive in human amniotic fluid (AF) and cause disease.
To identify genes that were up or down regulated in response to growth in AF, GAS was grown in human AF or standard
laboratory media (THY) and samples for expression microarray analysis were collected during mid-logarithmic, late-
logarithmic, and stationary growth phases. Microarray analysis was performed using a custom Affymetrix chip and
normalized hybridization values derived from three biological replicates were collected at each growth point. Ratios of AF/
THY above a 2-fold change and P-value ,0.05 were considered significant.
Principal Findings: The majority of changes in the GAS transcriptome involved down regulation of multiple adhesins and
virulence factors and activation of the stress response. We observed significant changes in genes involved in the arginine
deiminase pathway and in the nucleotide de novo synthesis pathway.
Conclusions/Significance: Our work provides new insight into how pathogenic bacteria respond to their environment to
establish infection and cause disease.
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Introduction
Group A Streptococcus (Streptococcus pyogenes, GAS) is an exclusively
human, Gram-positive pathogen that causes a broad variety of
diseases from mild pharyngitis and skin infections to necrotizing
fasciitis, streptococcal toxic shock syndrome, and non-suppurative
sequelae such as acute rheumatic fever or glumerulonephritis (for a
review see [1]). Since the 1980’s, GAS has re-emerged as an
important cause of severe invasive infections and is estimated to
cause approximately 500,000 deaths each year globally despite
available antibiotic treatment [2]. In the late 1800’s, GAS was
identified as a causative factor of puerperal sepsis – a severe
invasive infection in post partum women [3]. Due to advances in
hospital hygiene, namely physicians washing their hands between
deliveries, these types of GAS infections became less frequent.
However, in the last three decades there has been a resurgence in
GAS infections of the female urogenital tract and vulvovaginatis in
pre-pubescent females, and invasive postpartum disease now
accounts for approximately 2.2% of invasive GAS diseases [4].
Women with pre-existing throat infections or disrupted mucosal
and skin barriers during pregnancy and delivery are particularly
susceptible [4].
GAS strains are classified based on the aminoterminal sequence
of the M protein, a polymorphic cell surface adhesin and anti-
phagocytic factor [1]. Among the various GAS serotypes, serotype
M28 strains are a common cause of invasive disease and have an
unusual propensity to cause vaginitis and postpartum infections
[4–6]. Full-genome sequence analysis of an M28 strain provided
the first insight into the underlying molecular mechanism for the
ability of these strains to cause a disproportionate number of
postpartum infections [5]. Green et al. identified a mobile genetic
element, named Region of Difference (RD) 2, that was present in
all serotype M28 strains analyzed and a subset of other M serotype
strains that have been linked epidemiologically to maternal-
neonatal infections [5]. Interestingly, RD2 shares extensive
similarity with regions in group B Streptococcus (Streptococcus agalactiae,
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infections, and genes in groups C and G Streptococcus (Sitkiewicz I.,
Green NM., and Musser JM, unpublished) that can also cause
severe invasive infections [8,9].
As mentioned previously, GAS is capable of causing a wide
range of diseases by successfully colonizing a variety of anatomical
sites. Transcriptome analyses of GAS grown in blood, saliva,
epithelial cells, and polymorphonuclear leukocytes (PMNs) have
revealed that GAS is extremely adaptable and modifies its
transcriptome based on environmental signals [10–13]. To
establish infection in the female urogenital tract, GAS must
survive and replicate in a bacteriostatic host environment. The
ability of GBS to persist and replicate in human amniotic fluid
(AF) [14] is an important contributing factor to its ability to cause
severe pre- and postpartum infections, despite AF having
antibiotic properties towards other bacterial species [15]. Because
M28 GAS strains contain the RD2 element and cause a
disproportionate number of postpartum infections, we hypothe-
sized that serotype M28 GAS would be able to survive and persist
in human AF, similarly to GBS. To initially characterize the
interaction of pathogenic GAS within this specific host niche, we
used an ex vivo strategy to analyze the global transcriptional
response of GAS grown in human AF compared to GAS grown
under standard laboratory conditions.
Materials and Methods
Bacterial strains and routine growth
GAS strains MGAS6180 (serotype M28, RD2+) [5], and
MGAS 5005 (serotype M1, RD2-) [16] were grown in Todd
Hewitt medium with 0.5% yeast extract or on TSA II plates
supplemented with 5% sheep blood (BD Diagnostics) at 37uCi n
5% CO2.
Growth of bacteria in AF
Human (AF) was collected from pregnant women seen at The
Methodist Hospital, Houston, Texas, or Weill Medical College of
Cornell University in New York City. Samples were collected in
accordance with an exempt human subjects protocol approved by
the Institution Review Board of each institution. The study
involved collection of existing diagnostic specimens routinely
collected during clinical procedures as amniocenteses and would
have been otherwise discarded. Specimens were stripped of all
identifiers and processed in a manner that subjects cannot be
directly or indirectly identified.
AF samples were tested to determine if they supported bacterial
growth. GAS cells were grown overnight in THY, washed twice in
sterile PBS, and re-suspended in PBS to 1006. Ten ml of the 1006
bacteria suspension were diluted further in PBS and were used to
inoculate each 250 ml sample of heat inactivated (95uC, 5 min) AF,
resulting in a final average inoculum of ,10
4 CFU/ml. Samples
were incubated at 37uC with 5% CO2 for 24 h. To avoid THY
Figure 1. Characterization of growth of GAS in AF. A. Individual specimens of AF support growth of GAS at various levels after 24 h of
incubation; initial inoculum ,10
4 CFU/ml. B. Growth densities of GAS (CFU/ml) in THY and AF.
doi:10.1371/journal.pone.0009785.g001
Figure 2. Number of genes differentially expressed in response
to AF in ML, LL and S phases. Upward arrows represent the number
of transcripts with increased expression in AF in ML, LL and S phases;
the downward arrows represent the number of transcripts with
increased expression in THY (down regulated in AF) in ML, LL and S
phases. Intersections of the Venn diagram indicate number of
differentially expressed genes during more than one growth phase.
doi:10.1371/journal.pone.0009785.g002
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1:50 or 1:25 into a fresh aliquot of AF after the first 24 h. Aliquots
were removed, serially diluted, and plated on TSA II plates (BD
Diagnostics) every hour for the first 12 h and every 12 h thereafter
for CFU enumeration. AF samples that supported growth of GAS
were pooled and used for the microarray analysis. Samples were
collected from three pooled AF cultures (biological replicates) after
3.5, 5, and 9 hours of growth in AF, which corresponds to bacteria
in mid log (ML) growth phase, late log (LL, time point
corresponding with the transition from log to stationary phase)
and stationary (S) phase, respectively. Bacteria grown in THY
laboratory medium were collected in ML, LL and S phase from
three independent cultures (biological replicates).
RNA isolation
The bacteria used for RNA isolation were mixed with 2 volumes
of RNA Protect reagent (Qiagen) and cells were collected by
centrifugation and stored at 280uC until processing. RNA from
GAS was isolated as described previously [17]. All samples were
processed at the same time to minimize experimental error.
Reverse transcription, cDNA fragmentation, and labeling for all
samples were performed as described previously [17].
Microarray analysis
Microarray analysis was performed using a custom-made
Affymetrix chip [18] that contained 1929 redundant probes
representing the core GAS chromosome and 289 redundant
probes unique for MGAS6180. A total of 1765 MGAS6180 genes
were represented on the array. Chip hybridization and data
acquisition and processing were performed as described [19].
Samples used for microarray analysis were collected from cultures
in THY and AF at mid logarithmic (ML), late logarithmic (LL)
and stationary (S) growth phases. The average expression values
for each transcript in AF in each growth phase was divided by the
average expression in THY to generate AF/THY ratios and
degree of changes. Genes that had a two-fold change of expression
or greater in AF and were statistically significant (P,0.05) were
included in the analysis.
The data is deposited in MIAME-compliant GEO database
under accession number GSE19985.
Figure 3. Dynamics of gene expression of GAS genes in ML, LL, and S phase in response to AF. Each dot represents a single transcript
and its coordinates are the average level of expression in THY (x-axis) and AF (y-axis). The dotted lines denote 2-fold change in transcription.
Transcripts below the lower dotted line are more highly expressed in THY, transcripts above the upper dotted line are more highly expressed in AF.
Thick black lines denote 10-fold differences in transcript level between the studied conditions.
doi:10.1371/journal.pone.0009785.g003
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Characterization of GAS growth in AF
Human AF is a nutritionally poor environment. AF is composed
primarily of water and low amounts of sugars and proteins, levels
of which decrease as the pregnancy nears term [20]. Recent
detailed compositional analysis of AF revealed the presence of
multiple proteins (serum albumin, transferrin, a-I-Antitripsin, a-
fetoprotein, calpain 6, pinin, type XIII collagen, immunoglobulins)
[21], glucose, fructose, lipids, hormones (estrogen and progester-
one), and epithelial cells. Sources of AF are predominantly fetal
urine (,900 ml per day influx at term), tracheal fluid, fetal lung
fluid, and water and solvents transferred between AF and fetal
blood in placenta [22].
GAS rarely causes septic abortions [4]; however, after
disruption of membranes, release of AF can change the
environment of the female genital tract by increasing pH from
acidic to neutral/slightly alkaline and affect balance of natural
bacterial vaginal flora. GAS grows better in neutral than acidic pH
[23], therefore pH change can promote growth of colonizing
pathogens and postpartum infection. Because GAS is able to cause
postpartum infections suggests that it is able to survive in an
environment containing AF.
Individual specimens of AF collected from women at various
stages of pregnancy can vary in their bacteriostatic properties,
primarily due to the activity of lysozyme, immunoglobins, and
b2lysin [24–26]. In general, samples from early stage pregnancies
are less bacteriostatic than samples from late stage pregnancies
[27]. In addition, bacteriostatic properties of AF also depend on
the presence of meconium and iron availability [28]. Often the
presence of meconium in AF is used to predict the likelihood of the
mother developing a postpartum or intrapartum bacterial
infection [29].
Therefore we wanted to determine if GAS can survive in
bacteriostatic AF and if so, what transcriptional changes it
undergoes to achieve this.
To determine if AF had antimicrobial properties towards GAS,
we tested samples collected from separate individuals at different
stages of pregnancy. About half of the tested specimens did not
support the growth of GAS (Fig 1A). Observed inhibition of GAS
growth did not correlate with the gestation period (data not
shown), and was instead patient specific and influenced by
unknown factors. Visual inspection of AF specimens did not allow
determination of the presence of meconium. Growth of GAS in
AF was not restricted to the serotype M28 strain, as serotype M1
strain MGAS5005 grew at a comparable density to the M28 strain
Table 1. Differential expression of genes encoding known GAS virulence factors upon contact with AF.
6180 SF370 Locus ML LL S Descriptions
M28_Spy0105 24.20 212.76 228.84 Fibronectin-binding protein
M28_Spy0107 - 22.49 29.14 27.83 Fibronectin-binding protein
M28_Spy0109 SPy0128 - 22.33 25.79 25.36 Fibronectin-binding protein
M28_Spy0113 22.49 22.64 216.21 Collagen adhesion protein
M28_Spy0754 SPy1054 - 22.41 21.82 Collagen-like surface protein
M28_Spy1675 sclA 2167.84 213.82 22.83 Collagen-like surface protein
M28_Spy1696 SPy2007 lmb 22.90 25.03 Laminin-binding surface protein
M28_Spy1702 SPy2018 emm 221.63 23.84 M protein
M28_Spy1715 253.54 28.97 23.47 Fibronectin-binding protein
M28_Spy1716 275.85 215.05 25.01 Fibronectin-binding protein
M28_Spy1336 253.13 290.92 2133.85 R28 protein
M28_Spy0139 SPy0167 slo 245.03 2.68 Streptolysin O
M28_Spy0540 SPy0738 sagA 22.06 Streptolysin S precursor
M28_Spy0541 SPy0739 sagB 212.20 Streptolysin S biosynthesis protein
M28_Spy0542 SPy0740 sagC 218.65 Streptolysin S biosynthesis protein
M28_Spy0543 SPy0741 sagD 215.04 Streptolysin S biosynthesis protein
M28_Spy0544 SPy0742 sagE 215.65 Streptolysin S biosynthesis protein
M28_Spy0545 SPy0743 sagF 215.06 Streptolysin S biosynthesis protein
M28_Spy0546 SPy0744 sagG 218.88 Streptolysin S export ATP-binding protein
M28_Spy0547 SPy0745 sagH 216.89 Streptolysin S export protein
M28_Spy0548 SPy0746 sagI 214.21 Streptolysin S export protein
M28_Spy0180 SPy0212 speG 22.59 Enterotoxin
M28_Spy0969 2.53 Enterotoxin
M28_Spy0953 SPy1273 cfa 15.18 2.52 cAMP factor
M28_Spy0968 SPy1436 spd3 2.26 Streptodornase (EC 3.1.21.1)
M28_Spy0329 SPy0416 Spy
CEP
216.21 22.50 Endopeptidase lactocepin
M28_Spy1700 SPy2010 scpA 247.34 22.64 C5A peptidase precursor (EC 3.4.21.-)
Values represent fold change in expression in AF at ML, LL, and S growth phases compared to expression in THY medium.
doi:10.1371/journal.pone.0009785.t001
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shown). In conclusion, unlike many other bacteria, GAS can
survive and grow in some AF specimens, which could have
important implications for its ability to cause postpartum
infections.
To further characterize the growth of GAS in AF, we pooled
all AF specimens that supported growth of GAS and performed
growth curves with two different starting inocula and compared it
to GAS grown in laboratory medium (THY) (Fig. 1B). Interest-
ingly, GAS grown in AF reached similar density (around
2610
7 CFU/ml) in stationary phase, despite a three-fold
difference in starting inocula. Similar cell density was observed
after 48h of incubation in AF. This suggests that the limited
nutrient availability of AF could not sustain higher density
growth.
Microarray analysis: general quantitative trends in
response to AF
To characterize the transcriptional response of GAS grown in AF
we utilized an ex vivo microarray approach that has been used
previously to characterize the interactions of GAS with various
environments such as blood and saliva [10,11]. We detected 859
differentially expressed genes fulfilling the criteria of differentially
expressed gene (,49% of genespresenton the array). Over 250 genes
were differentiallyexpressed in ML and LL phases and the number of
differentially expressed genes increased and reached maximum in S
phase (Figures 2 and 3). The majority of these genes in ML and LL
phases were up regulated rather than down regulated. This differs
from the response of GBS grown in AF [19], in which the majority of
genes are down regulated when compared to laboratory conditions
and the bulk of changes are observed during the transition from
Table 2. Differential expression of RD2 genes in response to AF.
Gene ML P LL S Putative function note
M28_Spy1304 10.19 6.76 16.10 + Hypothetical Protein
M28_Spy1305 2.39 + 2.43 + 1.75 + Hypothetical membrane protein
M28_Spy1306 10.06 + 7.60 + 2.47 Cell surface protein Virulence
M28_Spy1307 5.13 3.98 + 1.08 Hypothetical exported protein Virulence
M28_Spy1308 5.52 2.65 3.81 + Hypothetical exported protein Virulence
M28_Spy1309 1.54 + 1.71 + 1.70 + Hypothetical protein
M28_Spy1310 3.41 3.13 + 1.78 Membrane protein
M28_Spy1311 Not detected
M28_Spy1312 Not detected
M28_Spy1313 8.70 6.23 2.28 Hypothetical membrane protein
M28_Spy1314 5.17 4.37 + 3.00 hypothetical protein
M28_Spy1315 5.69 7.31 + 3.42 Hypothetical protein
M28_Spy1316 9.67 8.45 6.03 Hypothetical protein
M28_Spy1317 35.90 12.95 3.67 Hypothetical protein
M28_Spy1318 3.81 2.69 6.31 + Hypothetical protein
M28_Spy1319 Not detected
M28_Spy1320 11.20 36.55 + 10.89 + Hypothetical cytosolic protein
M28_Spy1321 Not detected
M28_Spy1322 6.26 4.41 2.37 FtsK SpoIIIE family
M28_Spy1323 9.05 + 6.88 + 1.61 Hypothetical cytosolic protein
M28_Spy1324 5.80 7.41 + 2.68 Hypothetical cytosolic protein
M28_Spy1325 3.99 + 2.28 1.72 Cell surface protein Virulence
M28_Spy1326 2.18 + 1.08 21.29 + M like protein Virulence
M28_Spy1327 18.65 6.43 4.84 Hypothetical cytosolic protein
M28_Spy1328 Not detected
M28_Spy1329 12.91 5.16 2.98 Transcriptional Cro CI regulator
M28_Spy1330 1.80 + 1.75 + 2.23 + Transcriptional Cro CI regulator
M28_Spy1331 2.22 + 2.51 + 4.28 + Hypothetical cytosolic protein
M28_Spy1332 2.42 + 2.50 + 8.66 + Hypothetical exported protein Virulence
M28_Spy1333 1.89 + 1.69 + 5.46 + Hypothetical cytosolic protein
M28_Spy1334 1.74 + 2.35 + 6.34 + DNA-damage-inducible protein J
M28_Spy1335 1.20 1.36 3.20 Transposase
M28_Spy1336 253.13 + 290.92 + 2133.85 + R28 Cell surface protein Virulence
M28_Spy1337 25.18 + 28.50 + 27.93 + Transcriptional regulator
Values represent fold change in expression in AF at ML, LL, and S growth phases compared to expression in THY medium. +:P ,0.05.
doi:10.1371/journal.pone.0009785.t002
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transcriptional changes in GAS is shown in Table S1 and comparison
of gene expression between GAS and GBS in Table S2.
Expression of virulence factors
Because GAS causes severe invasive postpartum diseases, we
were interested in determining which virulence factors exhibited a
Table 3. Differential expression of stress response genes in response to AF.
6180 SF370 Locus ML LL S Descriptions
M28_Spy0317 SPy0395 clpP 3.01 proteolytic subunit clpP
M28_Spy1179 SPy1509 clpE 2.01 2.64 2.04 ATP-binding subunit clpE
M28_Spy0659 SPy0873 - 2.05 GTP pyrophosphokinase
M28_Spy0671 clpX 26.23 ATP-binding subunit clpX
M28_Spy0674 SPy0888 clpL 3.29 6.32 ATP-binding subunit clpL
M28_Spy0943 SPy1260 - 2.66 General stress protein, Gls24 family
M28_Spy0945 SPy1262 - 2.59 General stress protein, Gls24 family
M28_Spy1286 SPy1557 msrA 3.73 2.41 Peptide methionine sulfoxide reductase msrA
M28_Spy0755 SPy1055 msrB 5.36 4.95 8.23 Peptide methionine sulfoxide reductase msrB
M28_Spy1503 SPy1780 - 2.71 Universal stress protein family
M28_Spy1562 - 2102.42 217.90 Universal stress protein family
M28_Spy0659 SPy0873 - 2.05 GTP pyrophosphokinase
M28_Spy1674 SPy1981 relA 22.11 22.15 GTP pyrophosphokinase
M28_Spy1747 SPy2070 groEL 2.34 60 kDa chaperonin GROEL
M28_Spy1748 SPy2072 groES 2.36 10 kDa chaperonin GROES
M28_Spy1751 SPy2077 csp 2.24 8.50 Cold shock protein
Values represent fold change in expression in AF at ML, LL, and S growth phases compared to expression in THY medium.
doi:10.1371/journal.pone.0009785.t003
Table 4. Differential expression of selected regulatory systems in response to AF.
6180 SF370 Locus ML LL S Descriptions
M28_Spy0104 SPy0124 rofA 22.09 23.56 22.69 Transcriptional regulator RofA
M28_Spy0122 SPy0146 sloR 211.53 213.76 Transcriptional regulator pfoR
M28_Spy0198 SPy0242 fasB 23.31 Sensory transduction protein kinase FasB
M28_Spy0199 SPy0244 fasC 22.08 22.09 24.77 Sensory transduction protein kinase FasC
M28_Spy0200 SPy0245 fasA 23.61 Response regulator FasA
M28_Spy0356 SPy0450 mtsR 3.96 Iron-dependent repressor
M28_Spy0412 SPy0514 ccpA 23.65 Catabolite control protein A
M28_Spy0465 SPy0584 ptsK 2.66 HPR(SER) kinase
M28_Spy0761 SPy1061 - 24.83 Two-component sensor kinase yesM
M28_Spy0762 SPy1062 - 23.19 Two-component response regulator yesN
M28_Spy0807 SPy1106 dpiA 2.09 Transcriptional regulatory protein dpiA
M28_Spy0808 SPy1107 dpiB 2.16 Sensor kinase dpiB
M28_Spy0919 SPy1236 ciaH 23.35 Sensor protein ciaH
M28_Spy0920 SPy1237 ciaR 22.58 Transcriptional regulatory protein ciaR
M28_Spy1215 SPy1549 ahrC.2 216.22 Arginine repressor, argR
M28_Spy1346 SPy1587 - 24.45 Two-component response regulator yesN
M28_Spy1347 SPy1588 - 23.03 Two-component sensor kinase yesM
M28_Spy1373 SPy1621 yvqC 2.05 Two-component response regulator yvqC
M28_Spy1374 SPy1622 yvqE 2.28 3.93 Two-component sensor protein yvqE
M28_Spy1708 SPy2026 ihk 21.96 Two component system histidine kinase
M28_Spy1709 SPy2027 irr 21.58 Two-component response regulator
Values represent fold change in expression in AF at ML, LL, and S growth phases compared to expression in THY medium.
doi:10.1371/journal.pone.0009785.t004
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exception of CAMP factor, streptodornase, and one of the
enterotoxins (Table 1), we did not detect up regulation of virulence
factor expression. However, we did detect massive down
regulation of genes encoding proteins involved in adhesion, such
as multiple fibronectin, collagen and laminin binding proteins, M
protein, the gene encoding R28 protein (M28_Spy1336), and
streptolysin S. Down regulation of multiple adhesins and cell
surface proteins could be a mechanism to evade the host immune
response. The genes encoding two peptidases that interact with the
host immune response, C5A peptidase and SpyCEP, were
expressed at much lower levels in AF than in THY (Table 1).
C5A peptidase has been also shown to facilitate fibronectin-
independent invasion of epithelial cells [30]. Similar down
regulation of adhesins and capsule was observed in GBS when
grown in AF [19].
R28 is an adhesin encoded by the RD2 element present in
MGAS6180 and several other GAS strains [5]. It is a known
virulence factor that increases attachment of GAS to cervical cells
[31]. Its down regulation might be connected to down regulation
of M28_Spy1337, which encodes a putative regulator; however,
this has yet to be tested experimentally. In addition to R28, we
observed an increase in transcription levels for multiple genes
encoded by RD2 (Table 2). The RD2 element has been suggested
to be involved in pathogenesis and adaptation to specific
environments [5]. Interestingly, a large number of RD2 genes
differed in their expression among biological replicates; therefore
the calculated P value in many cases was greater than 0.05.
Stress response of GAS and GBS to AF
In contrast to GBS, which does not increase transcription of
genes encoding proteins involved in the stress response [19], GAS
Table 5. Differential expression of selected genes responsible for transport and metabolism of carbohydrates.
6180 SF370 Locus ML LL S Descriptions
M28_Spy0757 SPy1057 - 23.86 211.47 218.53 PTS system, mannose fructose family
M28_Spy0759 SPy1059 ptsC 24.04 27.65 213.42 PTS system, mannose fructose family
M28_Spy0958 SPy1280 glmS 22.80 22.01 Glucosamine–fructose-6-phosphate aminotransferase
M28_Spy1036 SPy1291 glgP 22.16 Maltodextrin phosphorylase
M28_Spy1037 SPy1292 malM 214.96 4-alpha-glucanotransferase
M28_Spy1039 SPy1294 malE 24.94 Maltose maltodextrin-binding protein
M28_Spy1041 SPy1296 malG 2.19 Maltose transport system permease protein
M28_Spy1044 SPy1299 malD 234.73 Maltodextrin transport system permease protein
M28_Spy1045 SPy1301 malC 238.81 Maltodextrin transport system permease protein
M28_Spy1046 SPy1302 amyA 282.63 Cyclodextrin glucanotransferase
M28_Spy1047 SPy1304 amyB 2.06 224.86 Neopullulanase
M28_Spy1048 SPy1306 malX 237.14 Maltose maltodextrin-binding protein
M28_Spy1349 SPy1592 - 242.74 Sugar-binding protein
M28_Spy1350 SPy1593 - 213.77 Sugar transport system permease protein
M28_Spy1351 SPy1595 - 27.07 Sugar transport system permease protein
M28_Spy1354 SPy1599 - 22.17 Beta-glucosidase
M28_Spy1438 SPy1704 lacD.1 249.45 Tagatose-bisphosphate aldolase
M28_Spy1440 SPy1707 lacB.1 2170.54 Galactose-6-phosphate isomerase lacB subunit
M28_Spy1441 SPy1708 lacA.1 2100.49 Galactose-6-phosphate isomerase lacA subunit
M28_Spy1442 SPy1709 - 2.40 PTS system, galactose-specific IIC component
M28_Spy1443 SPy1710 - 226.62 PTS system, galactose-specific IIB component
M28_Spy1444 SPy1711 - 257.34 PTS system, galactose-specific IIA component
M28_Spy1445 SPy1712 lacR.1 22.47 Lactose phosphotransferase system repressor
M28_Spy1622 SPy1916 lacG 267.36 6-phospho-beta-galactosidase
M28_Spy1624 SPy1918 lacF 28.85 PTS system, lactose-specific IIA component
M28_Spy1625 SPy1919 lacD.2 2122.01 Tagatose-bisphosphate aldolase
M28_Spy1626 SPy1921 lacC.2 255.33 Tagatose-6-phosphate kinase
M28_Spy1627 SPy1922 lacB.2 221.89 Galactose-6-phosphate isomerase lacB subunit
M28_Spy1628 SPy1923 lacA.2 269.34 Galactose-6-phosphate isomerase lacA subunit
M28_Spy1629 SPy1924 lacR.2 23.72 Lactose phosphotransferase system repressor
M28_Spy1668 SPy1972 pulA 25.30 Pullulanase
M28_Spy1767 SPy2096 dexS 26.18 239.01 Trehalose-6-phosphate hydrolase
M28_Spy1768 SPy2097 - 28.81 243.06 PTS system, trehalose-specific IIBC component
Values represent fold change in expression in AF at ML, LL, and S growth phases compared to expression in THY medium.
doi:10.1371/journal.pone.0009785.t005
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increased transcription of the genes encoding proteolytic complex
composed of ATPase and catalytic subunits ( clpP, clpE, clpX, and
clpL) known to be stress effectors in streptococci [32,33], the
GroEL and GroES chaperonins, members of the Gls24 family of
stress proteins (stress and starvation inducible genes in Enterococcus
faecalis, [34]), and a putative GTP pyrophosphokinase (Table 3).
Expression of the gene M28_Spy1562 that encodes a putative stress
protein, was dramatically decreased in AF; however, its function in
GAS is unknown. We also observed lowered expression of the relA
gene which is major regulator of stringent control in GAS [35].
Regulatory events during growth in AF
We observed a large number of significant changes in
transcription of regulatory genes (Table S1). Because the exact
functions of many of these are unknown, it is impossible to predict
the significance of these changes. However, we did detect changes
in expression of known GAS regulators (Table 4) such as RofA/
RALP that are involved in the regulation of virulence factor
expression, namely adhesins [36]. Down regulation of rofA in
response to AF might be partially responsible for the observed
decreases in the transcription of the genes encoding fibronectin
binding proteins. The decreased gene expression of the regulator
ahrC.2 may be responsible for the observed changes in expression
of genes involved in arginine metabolism (see below). Two other
differentially expressed regulators were recently shown to be
involved in GAS pathogenesis. The first, MtsR, is a regulator of
ion transport and is involved in the development of necrotizing
fasciitis [37,38] The second, CcpA, links GAS virulence and
carbohydrate metabolism [18]. In addition to individual regula-
tors, we detected differential expression of seven (of 13) two
component systems (TCSs) encoded by GAS. In the absence of
regulation by alternative sigma factors in GAS, it is believed that
concerted activity of regulons and TCSs is responsible for reaction
of GAS to the environment. FasBCA and ihk/irr were shown to be
involved in regulation of GAS pathogenesis. FasBCA controls
Table 6. Differential expression of genes involved in the transport and metabolism of amino acids, peptides, and amines.
6180 SF370 Locus ML LL S Descriptions
Proteases
M28_Spy0463 SPy0581 - 22.95 Metallopeptidase, SprT family
M28_Spy0470 SPy0590 - 22.23 22.82 Peptidase family U32
M28_Spy0471 SPy0591 - 22.10 Peptidase family U32
M28_Spy0572 SPy0775 - 2.31 Neutral zinc metallopeptidase family
M28_Spy1136 SPy1402 - 34.77 Peptidase family S11
M28_Spy1397 SPy1651 pepC 21.98 Aminopeptidase C
M28_Spy1565 SPy1858 pepXP 2.31 4.45 Xaa-Pro dipeptidyl-peptidase
M28_Spy1744 SPy2066 - 24.28 222.44 Dipeptidase A (EC 3.4.13.-)
M28_Spy1766 SPy2095 pepO 22.78 Oligoendopeptidase O (EC 3.4.24.-)
Arginine metabolism
M28_Spy0575 SPy0778 - 22.35 Arginine-binding protein
M28_Spy1176 SPy1506 artP 2.95 2.12 2.07 Arginine transport ATP-binding protein
M28_Spy1177 SPy1507 artQ 2.50 2.08 Arginine transport system permease protein
M28_Spy1208 SPy1541 arcC 28.01 2877.27 Carbamate kinase
M28_Spy1209 SPy1542 - 2199.49 Xaa-His dipeptidase
M28_Spy1210 SPy1543 - 22.55 2191.92 Arginine ornithine antiporter
M28_Spy1211 SPy1544 arcB 24.96 2212.09 Ornithine carbamoyltransferase
M28_Spy1213 SPy1547 arcA 28.87 2712.24 Arginine deiminase
Branched chain amino acids
M28_Spy0266 SPy0323 braB 5.13 5.26 2.21 Branched-chain amino acid carrier protein
M28_Spy0693 SPy0911 bcaT 2.13 3.48 Branched-chain amino acid aminotransferase
Di- and oligopeptide transport
M28_Spy1689 SPy2000 dppA 24.23 22.68 Dipeptide-binding protein
M28_Spy1690 SPy2001 dppB 23.39 22.70 Dipeptide transport system permease protein
M28_Spy1691 SPy2002 dppC 24.57 22.82 22.61 Dipeptide transport system permease
M28_Spy1692 SPy2003 dppD 24.19 22.58 22.46 Dipeptide transport ATP-binding protein
M28_Spy1693 SPy2004 dppE 24.21 22.76 Dipeptide transport ATP-binding protein
M28_Spy0245 SPy0294 oppB 2.55 Oligopeptide transport system permease
M28_Spy0246 SPy0295 oppC 2.01 Oligopeptide transport system permease
M28_Spy0247 SPy0296 oppD 1.75 Oligopeptide transport ATP-binding
M28_Spy0248 SPy0297 oppF 1.89 Oligopeptide transport ATP-binding
Values represent fold change in expression in AF at ML, LL, and S growth phases compared to expression in THY medium.
doi:10.1371/journal.pone.0009785.t006
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proteins [39,40]. The Ihk/Irr system is involved in GAS survival
upon contact with human PMNs [12]. Circuits regulated by
two other two component systems, M28_Spy0761/2 (SPy1061/2
in SF370 strain) and M28_Spy0807/8 (SPy1106/7 in SF370
strain), were studied by microarray analysis [17] and were shown
to be involved in regulation of genes involved in carbohydrate
and malate utilization, respectively. M28_Spy0919/20, M28_
Spy1346/7 and M28_Spy1373/4 (SPy1236/7, SPy1587/8,
SPy1621/2 in SF370 strain, respectively) have not been charac-
terized thus far.
Metabolic adaptation to AF environment
A recently performed transcriptional analysis of GBS grown in
AF revealed dramatic changes in expression of genes that control
metabolism of carbohydrates, amino acids, and nucleotides [19],
which presumably reflects an adaptive response to limited nutrient
availability. We observed similar trends in the metabolic response
of GAS to AF, with the majority of differences occurring in
expression of genes involved in carbohydrate utilization (Table
S2). In contrast to GBS that up regulates genes involved in
carbohydrate utilization, GAS down regulates genes belonging to
this category. Clear examples are the M28_Spy1036-1048 (mal
genes), M28_Spy1349-1354, M28_Spy1438-1445 (lac.1 genes),
and M28_Spy1622-1629 (lac.2 genes) loci (Table 5). The Mal locus
has been shown to be involved in GAS persistence in the
oropharynx [41], and lac loci are not only involved in fermentation
and energy production via the tagatose pathway, but also link
metabolism and the regulation of virulence [42].
Another category of metabolic genes affected by growth in AF
were genes involved in protein and amino acid utilization. We
observed differential expression of multiple proteases, and di- and
oligopeptide transport systems (Table 6). Similarly to GBS, we
observed up regulation of genes involved in uptake and utilization
of branched chain amino acids (BCAA, valine, leucine, and
isoleucine). GBS is auxotrophic in respect to BCAA and mobilizes
Figure 4. Changes in transcription of genes encoding predicted enzymes in the purine and pyrimidine biosynthetic pathway in GAS
and GBS in response to AF. Both GAS and GBS exhibit similar changes in the expression of genes encoding enzymes involved in nucleotide
biosynthesis. Changes in transcription of GBS genes from [19], changes in transcription of GAS genes, this work. Light green: genes down regulated 2
to 5 fold upon contact with AF; dark green: above 5 fold. Light orange: genes up regulated 2 to 5 fold upon contact with AF; dark orange: above 5
fold. R5P, ribose 5-phosphate; PRPP, phosphoribosylpyrophosphate; PRA, 5-phospho-b-D-ribosylamine; GAR, 59-phosphoribosylglycinamide; FGAR,
59-phosphoribosyl-N-formylglycinamide; FGAM, 59-phosphoribosyl-N-formylglycinamidine; AIR, 59-phosphoribosyl-5-aminoimidazole; NCAIR, 59-
phosphoribosyl-5-carboxyaminoimidazole; CAIR, 59-phosphoribosyl-5-aminoimidazole-4-carboxylate; SAICAR, 59-phosphoribosyl-4-(N-succino-car-
boxamide)-5-aminoimidazole; AICAR, 59-phosphoribosyl-4-carboximide-5-aminoimidazole ribonucleotide; FAICAR, 59-phosphoribosyl-4-carboximide-
5-formaminoimidazole; IMP, inosine 59-monophosphate; XMP, xanthosine monophosphate; GMP, guanosine monophosphate; GTP, guanosine
triphosphate; sAMP, adenylosuccinate; AMP, adenosine monophosphate; ATP, adenosine triphosphate.
doi:10.1371/journal.pone.0009785.g004
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could possibly employ the same mechanism to maximize nutrient
utilization.
The most dramatic changes in gene expression were observed in
genes encoding enzymes of the arginine deiminase pathway, which
were down regulated almost 900-fold upon contact with AF
(Table 6). The arginine deiminase pathway allows utilization of
arginine as a carbon and energy source [43] and plays a role in the
modification of the environmental acidity [44,45]. Arginine
deiminase from the GAS Manfredo strain is also a potent inhibitor
of the proliferation of peripheral blood mononuclear cells [46].
However, arginine deiminase is not only an intracellular enzyme
Table 7. Differential expression of selected genes involved in nucleotide metabolism upon contact with AF.
6180 SF370 Locus ML LL S Descriptions
M28_Spy0022 SPy0024 - 36.60 10.73 35.84 Phosphoribosylaminoimidazole-succinocarboxamide synthase
M28_Spy0024 SPy0026 purF 24.03 10.89 13.45 Amidophosphoribosyltransferase
M28_Spy0026 SPy0028 purN 37.86 18.63 17.69 Phosphoribosylglycinamide formyltransferase
M28_Spy0027 purH 17.83 3.68 3.85 Phosphoribosylaminoimidazolecarboxamide formyltransferase
M28_Spy0029 SPy0032 purD 15.56 9.89 11.31 Phosphoribosylamine-glycine ligase
M28_Spy0030 SPy0033 purE 16.52 7.50 11.42 Phosphoribosylaminoimidazole carboxylase carboxyltransferase
M28_Spy0031 SPy0034 purK 6.05 11.19 Phosphoribosylaminoimidazole carboxylase NCAIR mutase
M28_Spy0064 SPy0074 adk 28.25 Adenylate kinase
M28_Spy0134 SPy0160 purA 3.17 Adenylosuccinate synthetase
M28_Spy0193 SPy0235 - 22.67 Deoxyuridine 5 -triphosphate nucleotidohydrolase
M28_Spy0316 SPy0392 upp 22.43 Uracil phosphoribosyltransferase
M28_Spy0334 SPy0425 nrdF.1 25.27 Ribonucleoside-diphosphate reductase beta chain
M28_Spy0335 SPy0426 nrdI 24.58 NrdI protein
M28_Spy0336 SPy0427 nrdE.1 22.37 Ribonucleoside-diphosphate reductase alpha chain
M28_Spy0597 SPy0803 cmk 2.59 Cytidylate kinase
M28_Spy0620 SPy0831 pyrP 6.66 Uracil permease
M28_Spy0622 SPy0833 carA 4.79 22.17 Carbamoyl-phosphate synthase small chain
M28_Spy0624 SPy0835 carB 5.93 22.87 Carbamoyl-phosphate synthase large chain
M28_Spy0658 SPy0872 - 68.19 15.18 11.50 5 -nucleotidase
M28_Spy0668 SPy0882 thyA 23.66 Thymidylate synthase
M28_Spy0679 SPy0894 deoD2 22.85 Purine nucleoside phosphorylase
M28_Spy0683 SPy0900 pyrF 3.45 Orotidine 5 -phosphate decarboxylase
M28_Spy0684 SPy0901 pyrE 4.03 Orotate phosphoribosyltransferase
M28_Spy0689 SPy0907 pyrC 2.82 2.39 2.51 Dihydroorotase
M28_Spy0708 SPy0927 apt 22.13 Adenine phosphoribosyltransferase
M28_Spy0821 SPy1123 - 2.04 Ribose-phosphate pyrophosphokinase
M28_Spy0831 SPy1135 guaC 68.20 23.60 95.96 GMP reductase
M28_Spy0832 SPy1136 xpt 40.85 90.15 Xanthine phosphoribosyltransferase
M28_Spy0833 SPy1137 - 9.77 45.75 76.46 Xanthine permease
M28_Spy0897 SPy1211 rnhB 2.92 8.45 Anaerobic ribonucleoside-triphosphate reductase
M28_Spy0899 SPy1213 fhs.1 5.53 4.21 Formate–tetrahydrofolate ligase
M28_Spy0914 SPy1228 - 2.11 Nucleoside-binding protein
M28_Spy1109 SPy1368 udk 22.04 Uridine kinase
M28_Spy1118 SPy1378 nrdF.2 2.32 Ribonucleoside-diphosphate reductase beta chain
M28_Spy1159 SPy1432 pyrD 2.15 Dihydroorotate dehydrogenase
M28_Spy1466 SPy1736 - 5.01 3.02 5.14 Guanine-hypoxanthine permease
M28_Spy1580 SPy1869 udp 22.83 Uridine phosphorylase
M28_Spy1599 SPy1894 pyrG 22.64 CTP synthase
M28_Spy1758 SPy2085 fhs.2 3.32 2.32 Formate–tetrahydrofolate ligase
M28_Spy1773 SPy2105 nrdG 22.00 22.45 Anaerobic ribonucleoside-triphosphate reductase activating protein
M28_Spy1777 SPy2110 nrdD 22.22 23.50 Anaerobic ribonucleoside-triphosphate reductase
M28_Spy1890 SPy2206 guaB 22.28 Inosine-5 -monophosphate dehydrogenase
Values represent fold change in expression in AF at ML, LL, and S growth phases compared to the expression in THY medium.
doi:10.1371/journal.pone.0009785.t007
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the GAS cell surface [47] and antibodies against this protein have
been recently reported to protect mice against GAS infection
(Walker MJ, Henningham A, Cork A, Cole JN, Ramachandran V
et al. (2008) Group A Anchorless Surface proteins. XVII
Lancefield International Symposium on Streptococci and Strep-
tococcal Diseases O9.2; Henningham A, Batzloff M, Cole JN,
Gillen C, Hartas J et al. (2008) Protection Against lethal
Streptococcus pyogenes challenge following vaccination with anchorless
cell wall-associated proteins. XVII Lancefield International
Symposium on Streptococci and Streptococcal Diseases P54). It
is possible that the lack of arginine deiminase on the surface is
linked to decreased recognition by the host immune response,
which would be consistent with the observed down regulation of
adhesins and other major surface proteins. Interestingly, fetal urine
(which is a major component of AF) flow and composition is
modulated by arginine levels [22], therefore bacterial arginine
metabolism could be linked to AF dynamics.
Arginine metabolism is linked via carbamate kinase to another
pathway – nucleotide synthesis (Figure 4). We observed dramatic
up regulation of genes involved in purine and pyrimidine
nucleotide biosynthesis pathways and down regulation of genes
encoding enzymes involved in salvage pathways (Table 7). The
extent of changes in GAS correlates well with changes detected in
GBS [19], and almost all of the enzymes in the nucleotide
metabolic pathways undergo the same directional changes
(Figure 4), what suggests direct influence of the AF environment.
Samant et al. [48] recently showed that multiple enzymes
involved in nucleotide metabolism are essential for growth of
Escherichia coli in human serum, and a bacterial growth defect can
be rescued by the addition of nucleotides to the serum. To test if a
lack of nucleotides or arginine/ornithine in the AF is a growth
limiting factor, we tested growth of GAS in AF with the addition of
selected amino acids and nucleotides (arginine, ornithine, adenine,
xanthine, and uracyl at concentrations corresponding to minimal
chemically defined media (CDM) concentrations for GAS [49]).
The observed culture densities after overnight growth did not
increase compared to the AF without any supplements (Figure 5).
Therefore, the lack of arginine and nucleotides in AF is not a
limiting factor for growth of GAS and up regulation of the
nucleotide synthesis pathway has a distinct function from
providing material for DNA synthesis. Multiple reports have
suggested a connection between nucleotide metabolism and
bacterial virulence [50]. Mereghetti et al. recently reported
changes in nucleotide metabolism in GBS during growth in blood
and as an effect of a temperature switch [51,52].
Summary
Group A Streptococcus, a causative agent of postpartum invasive
infections, is able to survive and multiply in AF. It is able to
multiply and survive over 48h in the AF environment. The
response of GAS is in many aspects similar to the response
exhibited by GBS; however, on the contrary to GBS, GAS exhibits
stronger stress response to the AF environment. GAS adapts to
growth in AF by differential regulation of genes involved in
arginine and nucleotide metabolism. In addition, GAS down
regulates multiple cell surface proteins, presumably to escape host
immune recognition.
Supporting Information
Table S1 Differential expression of all GAS genes in response to
AF. Changes in transcription of GAS genes upon contact with
amniotic fluid. All changes detected in transcription of GAS in
Figure 5. Addition of arginine, ornithine, purines and pirymidines does not increase growth of GAS in AF. Cell densities of GAS cultures
grown in pooled AF for 24 hours with addition of amino acids (arginine, ornithine) and nucleotides (xanthine, uracil, and adenine) at the
concentration that supports growth of GAS in minimal CDM [49].
doi:10.1371/journal.pone.0009785.g005
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expression in amniotic fluid compared to expression in THY; ML,
mid-logarithmic growth phase; LL, late-logarithmic growth phase;
S, stationary growth phase; cut-off two fold change with P value
less than 0.05. Positive values represent genes up-regulated in AF
(orange), negative values represent down-regulated (green, better
expressed in THY) genes. Rows marked grey denote transcripts
not detected during the experiment.
Found at: doi:10.1371/journal.pone.0009785.s001 (0.62 MB
XLS)
Table S2 Comparison of transcriptional changes between GAS
and GBS grown in AF. Differential expression of GAS and GBS
genes in response to AF - Changes in transcription of GAS and
GBS genes upon contact with amniotic fluid. Values represent fold
change in expression in amniotic fluid compared to expression in
THY; ML, mid-logarithmic growth phase; LL, late-logarithmic
growth phase; S, stationary growth phase; cut-off two fold change
with P value less than 0.05. Positive values represent genes up-
regulated in AF (orange), negative values represent down-
regulated (green, better expressed in THY) genes. GBS data after
reference [19].
Found at: doi:10.1371/journal.pone.0009785.s002 (0.34 MB
XLS)
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